Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues

Sarah McGuire, Fan Yuan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Interstitial transport of large molecules and nanoparticles is an important concern in nanomedicine-mediated cancer treatment. To that end, the current study was proposed to improve the transport through enlargement of extracellular space by treating tumors with hypertonic solution of mannitol and cytotoxic agents (e.g., ethacrynic acid [ECA]), which could effectively shrink and kill cells, respectively. In the study, the improvement in interstitial penetration of dextran was investigated ex vivo using rat fibrosarcoma tissues sectioned into 600 μm slices. Experimental data showed that the hypertonic solution was more effective than ECA for improving interstitial penetration of dextran with molecular weights ranging from 4000 to 2,000,000. The extent of improvement depended on the size of dextran molecules and the time when the treatment was applied. Results from the study suggested that increases in both size and connectedness of interstitial pathways were important for improvement of interstitial transport of large molecules and nanoparticles. From the Clinical Editor: This study reports on the optimization of interstitial transport both for large molecules and nanoparticles in nanomedicine-mediated cancer treatment. The study demonstrates that hypertonic solutions could efficiently lead to cancer cell shrinkage and more so than the applied cytotoxic agent thereby improving transport of chemotherapeutic entities.

Original languageEnglish (US)
Pages (from-to)1088-1095
Number of pages8
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume8
Issue number7
DOIs
StatePublished - Oct 1 2012

Fingerprint

Hypertonic Solutions
Macromolecules
Cell Size
Dextran
Tumors
Volume fraction
Dextrans
Nanoparticles
Tissue
Nanomedicine
Ethacrynic Acid
Medical nanotechnology
Molecules
Oncology
Cytotoxins
Neoplasms
Acids
Fibrosarcoma
Extracellular Space
Mannitol

Keywords

  • Drug delivery
  • Ethacrynic acid
  • Hypertonic solution
  • Mannitol

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues. / McGuire, Sarah; Yuan, Fan.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 8, No. 7, 01.10.2012, p. 1088-1095.

Research output: Contribution to journalArticle

@article{d277719a09404e789a3e433b3856441a,
title = "Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues",
abstract = "Interstitial transport of large molecules and nanoparticles is an important concern in nanomedicine-mediated cancer treatment. To that end, the current study was proposed to improve the transport through enlargement of extracellular space by treating tumors with hypertonic solution of mannitol and cytotoxic agents (e.g., ethacrynic acid [ECA]), which could effectively shrink and kill cells, respectively. In the study, the improvement in interstitial penetration of dextran was investigated ex vivo using rat fibrosarcoma tissues sectioned into 600 μm slices. Experimental data showed that the hypertonic solution was more effective than ECA for improving interstitial penetration of dextran with molecular weights ranging from 4000 to 2,000,000. The extent of improvement depended on the size of dextran molecules and the time when the treatment was applied. Results from the study suggested that increases in both size and connectedness of interstitial pathways were important for improvement of interstitial transport of large molecules and nanoparticles. From the Clinical Editor: This study reports on the optimization of interstitial transport both for large molecules and nanoparticles in nanomedicine-mediated cancer treatment. The study demonstrates that hypertonic solutions could efficiently lead to cancer cell shrinkage and more so than the applied cytotoxic agent thereby improving transport of chemotherapeutic entities.",
keywords = "Drug delivery, Ethacrynic acid, Hypertonic solution, Mannitol",
author = "Sarah McGuire and Fan Yuan",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.nano.2011.12.009",
language = "English (US)",
volume = "8",
pages = "1088--1095",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Improving interstitial transport of macromolecules through reduction in cell volume fraction in tumor tissues

AU - McGuire, Sarah

AU - Yuan, Fan

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Interstitial transport of large molecules and nanoparticles is an important concern in nanomedicine-mediated cancer treatment. To that end, the current study was proposed to improve the transport through enlargement of extracellular space by treating tumors with hypertonic solution of mannitol and cytotoxic agents (e.g., ethacrynic acid [ECA]), which could effectively shrink and kill cells, respectively. In the study, the improvement in interstitial penetration of dextran was investigated ex vivo using rat fibrosarcoma tissues sectioned into 600 μm slices. Experimental data showed that the hypertonic solution was more effective than ECA for improving interstitial penetration of dextran with molecular weights ranging from 4000 to 2,000,000. The extent of improvement depended on the size of dextran molecules and the time when the treatment was applied. Results from the study suggested that increases in both size and connectedness of interstitial pathways were important for improvement of interstitial transport of large molecules and nanoparticles. From the Clinical Editor: This study reports on the optimization of interstitial transport both for large molecules and nanoparticles in nanomedicine-mediated cancer treatment. The study demonstrates that hypertonic solutions could efficiently lead to cancer cell shrinkage and more so than the applied cytotoxic agent thereby improving transport of chemotherapeutic entities.

AB - Interstitial transport of large molecules and nanoparticles is an important concern in nanomedicine-mediated cancer treatment. To that end, the current study was proposed to improve the transport through enlargement of extracellular space by treating tumors with hypertonic solution of mannitol and cytotoxic agents (e.g., ethacrynic acid [ECA]), which could effectively shrink and kill cells, respectively. In the study, the improvement in interstitial penetration of dextran was investigated ex vivo using rat fibrosarcoma tissues sectioned into 600 μm slices. Experimental data showed that the hypertonic solution was more effective than ECA for improving interstitial penetration of dextran with molecular weights ranging from 4000 to 2,000,000. The extent of improvement depended on the size of dextran molecules and the time when the treatment was applied. Results from the study suggested that increases in both size and connectedness of interstitial pathways were important for improvement of interstitial transport of large molecules and nanoparticles. From the Clinical Editor: This study reports on the optimization of interstitial transport both for large molecules and nanoparticles in nanomedicine-mediated cancer treatment. The study demonstrates that hypertonic solutions could efficiently lead to cancer cell shrinkage and more so than the applied cytotoxic agent thereby improving transport of chemotherapeutic entities.

KW - Drug delivery

KW - Ethacrynic acid

KW - Hypertonic solution

KW - Mannitol

UR - http://www.scopus.com/inward/record.url?scp=84866517125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866517125&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2011.12.009

DO - 10.1016/j.nano.2011.12.009

M3 - Article

C2 - 22248816

AN - SCOPUS:84866517125

VL - 8

SP - 1088

EP - 1095

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 7

ER -